Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating activities:      
Consolidated net income (loss) $ 526.2 $ (378.1) $ 317.0
Adjustments to reconcile consolidated net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 399.3 337.3 315.9
Stock-based compensation expense 54.7 49.7 42.5
Deferred income taxes 66.5 (82.7) 1.3
Gain on fair market value adjustment of equity investments (149.5) 0.0 0.0
Changes in assets and liabilities, excluding effects of acquisitions:      
Accounts receivable, net (93.7) (61.3) (37.4)
Other assets, current and long-term 35.8 (78.8) (15.4)
Current and long-term liabilities, excluding debt 106.9 527.7 48.3
Cash provided by operating activities 946.2 313.8 672.2
Investing activities:      
Capital expenditures (421.3) (399.6) (321.9)
Acquisitions, net of cash acquired (61.4) (272.9) (138.3)
Cash received from sale of asset 0.0 0.0 5.6
Investment in unconsolidated affiliates, net (10.0) (25.0) (6.9)
Cash used in investing activities (492.7) (697.5) (461.5)
Financing activities:      
Net short-term repayments (0.7) (1.8) (959.2)
Payments on long-term debt (125.0) (250.0) (100.0)
Proceeds from issuance of long-term debt 1,123.3 998.3 994.5
Dividends paid to Equifax shareholders (189.5) (188.7) (187.9)
Dividends paid to noncontrolling interests (4.6) (6.6) (10.3)
Proceeds from exercise of stock options and employee stock purchase plan 41.7 22.3 11.8
Payment of taxes related to settlement of equity awards (15.9) (10.5) (19.7)
Payment of contingent consideration 0.0 0.0 (1.5)
Purchase of redeemable noncontrolling interests (9.0) 0.0 (30.9)
Debt issuance costs (9.8) (5.1) (7.8)
Other 0.3 0.0 0.0
Cash provided by (used in) financing activities 810.8 557.9 (311.0)
Effect of foreign currency exchange rates on cash and cash equivalents 19.0 3.5 (12.5)
Increase (decrease) in cash and cash equivalents 1,283.3 177.7 (112.8)
Cash and cash equivalents, beginning of period 401.3 223.6 336.4
Cash and cash equivalents, end of period $ 1,684.6 $ 401.3 $ 223.6